Title:
抗ＣＤ４０抗体及びその使用
Document Type and Number:
Japanese Patent JP5653945
Kind Code:
B2
Abstract:
The present invention includes compositions and methods for the expression, secretion and use of novel compositions for use as, e.g., vaccine and antigen delivery vectors, to delivery antigens to antigen presenting cells. In one embodiment, the vector is an anti-CD40 antibody, or fragments thereof, and one or more antigenic peptides linked to the anti-CD40 antibody or fragments thereof, including humanized antibodies.
Inventors:
バンチェレイア ジャック エフ．
ズラウスキ ジェラルド
ズラウスキ サンドラ
オー サンコン
ズラウスキ ジェラルド
ズラウスキ サンドラ
オー サンコン
Application Number:
JP2011554097A
Publication Date:
January 14, 2015
Filing Date:
March 05, 2010
Export Citation:
Assignee:
ベイラー リサーチ インスティテュートＢＡＹＬＯＲ ＲＥＳＥＡＲＣＨ ＩＮＳＴＩＴＵＴＥ
International Classes:
C12N15/09; A61K39/395; A61P1/04; A61P1/16; A61P3/10; A61P5/14; A61P7/00; A61P7/06; A61P11/00; A61P11/06; A61P15/00; A61P17/00; A61P17/04; A61P17/06; A61P17/14; A61P19/00; A61P19/02; A61P21/04; A61P25/00; A61P27/02; A61P27/16; A61P31/04; A61P31/10; A61P31/12; A61P33/00; A61P35/00; A61P35/02; A61P37/00; A61P37/06; A61P37/08; C07K16/28; C12P21/08
Attorney, Agent or Firm:
Masaki Hirota